{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:40:56Z","timestamp":1791945656976,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T00:00:00Z","timestamp":1688860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72074011"],"award-info":[{"award-number":["72074011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Center for Evidence Based Traditional Chinese Medicine","award":["2020YJSZX-2"],"award-info":[{"award-number":["2020YJSZX-2"]}]},{"name":"Drug Regulation of China","award":["(2021) 37-10"],"award-info":[{"award-number":["(2021) 37-10"]}]},{"name":"Brain science and brain-inspired intelligence technology","award":["2021ZD0200600"],"award-info":[{"award-number":["2021ZD0200600"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Study Objectives<\/jats:title>\n                    <jats:p>Sleep-related adverse effects during acute treatment with antidepressants undermine adherence and impede remission. We aimed to address subtypes of sleep-related adverse effects and depict the relationship between dose and sleep-related adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, Cochrane Central Register of Controlled Trials, and Web of Science for double-blind randomized controlled trials of depression published before April 30th, 2023. Eligible studies reporting sleep-related adverse effects during short-term monotherapy were included. The odds ratios (ORs) for sleep-related adverse effects were addressed with network meta-analysis. A Bayesian approach was used to depict the dose-effect relationship. Heterogeneity among studies was assessed using the \u03c42 and I2 statistics. Sensitivity analyses were performed without studies featuring high risk of bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Studies with 64 696 patients were examined from 216 trials. Compared to placebo, 13 antidepressants showed higher ORs for somnolence, of which fluvoxamine (OR = 6.32; 95% CI: 3.56 to 11.21) ranked the top. Eleven had higher risks for insomnia, reboxetine ranked the top (OR = 3.47; 95% CI: 2.77 to 4.36). The dose-effect relationships curves between somnolence or insomnia and dose included linear shape, inverted U-shape, and other shapes. There was no significant heterogeneity among individual studies. The quality of evidence for results in network meta-analyses was rated as very low to moderate by Grading of Recommendations Assessment, Development, and Evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most antidepressants had higher risks for insomnia or somnolence than placebo. The diverse relationship curves between somnolence or insomnia and dose of antidepressants can guide clinicians to adjust the doses. These findings suggest clinicians pay more attention to sleep-related adverse effects during acute treatment with antidepressants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sleep\/zsad177","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T09:17:53Z","timestamp":1688721473000},"source":"Crossref","is-referenced-by-count":48,"title":["Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-9944","authenticated-orcid":false,"given":"Shuzhe","family":"Zhou","sequence":"first","affiliation":[{"name":"Peking University Sixth Hospital, Peking University Institute of Mental Health , Beijing , China"},{"name":"NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital) , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Lv","sequence":"additional","affiliation":[{"name":"Peking University Sixth Hospital, Peking University Institute of Mental Health , Beijing , China"},{"name":"NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital) , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoxiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[{"name":"Peking University Sixth Hospital, Peking University Institute of Mental Health , Beijing , China"},{"name":"NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital) , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Tian","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University , Yantai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing , China"},{"name":"Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,9]]},"reference":[{"key":"2023101111242187400_CIT0001","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"2023101111242187400_CIT0002","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Clinical guidelines for the management of adults with major depressive disorder","volume":"61","author":"Kennedy","year":"20162016","journal-title":"Can J Psychiatry"},{"key":"2023101111242187400_CIT0003","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet."},{"key":"2023101111242187400_CIT0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-013-0129-4","article-title":"Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis","volume":"37","author":"Reichenpfader","year":"2014","journal-title":"Drug Saf."},{"key":"2023101111242187400_CIT0005","doi-asserted-by":"crossref","first-page":"110266","DOI":"10.1016\/j.pnpbp.2021.110266","article-title":"Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis","volume":"109","author":"Oliva","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"2023101111242187400_CIT0006","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00406-016-0706-5","article-title":"Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"267","author":"Kishi","year":"2017","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"2023101111242187400_CIT0007","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/ijms22031333","article-title":"Association of sleep architecture and physiology with depressive disorder and antidepressants treatment","volume":"22","author":"Hutka","year":"2021","journal-title":"Int J Mol Sci ."},{"key":"2023101111242187400_CIT0008","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1038\/s41598-022-18776-7","article-title":"Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis","volume":"12","author":"Zheng","year":"2022","journal-title":"Sci Rep."},{"key":"2023101111242187400_CIT0009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep."},{"key":"2023101111242187400_CIT0010","doi-asserted-by":"crossref","first-page":"e8748","DOI":"10.7717\/peerj.8748","article-title":"Association of sleep among 30 antidepressants: a population-wide adverse drug reaction study, 2004\u20132019","volume":"8","author":"Eugene","year":"2020","journal-title":"PeerJ."},{"key":"2023101111242187400_CIT0011","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JCP.0000000000000329","article-title":"Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression","volume":"35","author":"Alberti","year":"2015","journal-title":"J Clin Psychopharmacol."},{"key":"2023101111242187400_CIT0012","doi-asserted-by":"crossref","first-page":"114431","DOI":"10.1016\/j.bbr.2023.114431","article-title":"A comprehensive review and meta-analysis of neurological side effects related to second-generation antidepressants in individuals with major depressive disorder","volume":"447","author":"Zhou","year":"2023","journal-title":"Behav Brain Res."},{"key":"2023101111242187400_CIT0013","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab174","article-title":"Relative frequency of drug-induced sleep disorders for 32 antidepressants in a large set of internet user reviews","volume":"44","author":"Natter","year":"2021","journal-title":"Sleep."},{"key":"2023101111242187400_CIT0014","article-title":"A dose-effect network meta-analysis model with application in antidepressants using restricted cubic splines","volume":"998826288","author":"Hamza","year":"2022","journal-title":"Stat Methods Med Res."},{"key":"2023101111242187400_CIT0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ijnp\/pyz062","article-title":"Analysis of time-course, dose-effect, and influencing factors of antidepressants in the treatment of acute adult patients with major depression","volume":"23","author":"Cheng","year":"2020","journal-title":"Int J Neuropsychopharmacol."},{"key":"2023101111242187400_CIT0016","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa092","article-title":"Effects of agomelatine and mirtazapine on sleep disturbances in major depressive disorder: evidence from polysomnographic and resting-state functional connectivity analyses","volume":"43","author":"Mi","year":"2020","journal-title":"Sleep."},{"key":"2023101111242187400_CIT0017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/pr.117.014381","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol Rev."},{"key":"2023101111242187400_CIT0018","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"2023101111242187400_CIT0019","doi-asserted-by":"crossref","first-page":"741794","DOI":"10.3389\/fphar.2021.741794","article-title":"Pharmacological characterization of toludesvenlafaxine as a triple reuptake inhibitor","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Pharmacol."},{"key":"2023101111242187400_CIT0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ijnp\/pyab074","article-title":"Efficacy, safety, and tolerability of ansofaxine (ly03005) extended-release tablet for major depressive disorder: a randomized, double-blind, placebo-controlled, dose-finding, phase 2 clinical trial","volume":"25","author":"Mi","year":"2022","journal-title":"Int J Neuropsychopharmacol."},{"key":"2023101111242187400_CIT0021","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2023101111242187400_CIT0022","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A grade working group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"2023101111242187400_CIT0023","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med."},{"key":"2023101111242187400_CIT0024","first-page":"393","article-title":"Model-based network meta-analysis: a framework for evidence synthesis of clinical trial data","volume":"5","author":"Mawdsley","year":"2016","journal-title":"CPT: Pharmacometrics Sys Pharmacol"},{"key":"2023101111242187400_CIT0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/pst.432","article-title":"Fitting Emax models to clinical trial dose-response data","volume":"10","author":"Kirby","year":"2011","journal-title":"Pharm Stat."},{"key":"2023101111242187400_CIT0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002280050729","article-title":"Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin","volume":"56","author":"von Bahr","year":"2000","journal-title":"Eur J Clin Pharmacol."},{"key":"2023101111242187400_CIT0027","doi-asserted-by":"crossref","first-page":"e2311","DOI":"10.1002\/brb3.2311","article-title":"Drug use evaluation: a two-year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder","volume":"11","author":"Leung","year":"2021","journal-title":"Brain Behav"},{"key":"2023101111242187400_CIT0028","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12888-020-02711-z","article-title":"Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database","volume":"20","author":"Revet","year":"2020","journal-title":"BMC Psychiatry"},{"key":"2023101111242187400_CIT0029","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S2215-0366(19)30217-2","article-title":"Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis","volume":"6","author":"Furukawa","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"2023101111242187400_CIT0030","first-page":"611","article-title":"Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression","volume":"45","author":"Jarema","year":"2011","journal-title":"Psychiatr Pol."},{"key":"2023101111242187400_CIT0031","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082933","article-title":"Should trazodone be first-line therapy for insomnia? A clinical suitability appraisal","volume":"12","author":"Pelayo","year":"2023","journal-title":"J Clin Med"},{"key":"2023101111242187400_CIT0032","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1517\/14656566.2014.960842","article-title":"A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine","volume":"15","author":"Deardorff","year":"2014","journal-title":"Expert Opin Pharmacother."},{"key":"2023101111242187400_CIT0033","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0269881116628440","article-title":"The safety and tolerability of vortioxetine: analysis of data from randomized placebo-controlled trials and open-label extension studies","volume":"30","author":"Baldwin","year":"2016","journal-title":"J Psychopharmacol."},{"key":"2023101111242187400_CIT0034","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/03602532.2019.1620763","article-title":"Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects","volume":"51","author":"Costa","year":"2019","journal-title":"Drug Metab Rev."},{"key":"2023101111242187400_CIT0035","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1136\/bmjmed-2021-000017","article-title":"Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis","volume":"1","author":"Johnson","year":"2022","journal-title":"BMJ Medicine"}],"container-title":["SLEEP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsad177\/50929595\/zsad177.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/46\/10\/zsad177\/51943256\/zsad177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/46\/10\/zsad177\/51943256\/zsad177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T07:29:56Z","timestamp":1697009396000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsad177\/7221722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,9]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,7,9]]},"published-print":{"date-parts":[[2023,10,11]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsad177","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,7,9]]},"article-number":"zsad177"}}